We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

LabMedica

Download Mobile App
Recent News Expo Clinical Chem. Molecular Diagnostics Hematology Immunology Microbiology Pathology Technology Industry Focus

Lymphocyte Membrane Antigen Receptors Reside in Discrete Protein Islands

By LabMedica International staff writers
Posted on 27 Sep 2015
Image: Researchers previously assumed that receptors such as the antigen receptors of class Immunoglobulin M and Immunoglobulin D are freely diffusing and equally distributed molecules on the membrane. However, the new study shows that these antigen receptors are organized in different membrane compartments, also called \"protein islands\", with diameters of 150–200 nanometers (Photo courtesy of Reth Research Group, BIOSS Centre for Biological Signaling Studies of the University of Freiburg).
Image: Researchers previously assumed that receptors such as the antigen receptors of class Immunoglobulin M and Immunoglobulin D are freely diffusing and equally distributed molecules on the membrane. However, the new study shows that these antigen receptors are organized in different membrane compartments, also called \"protein islands\", with diameters of 150–200 nanometers (Photo courtesy of Reth Research Group, BIOSS Centre for Biological Signaling Studies of the University of Freiburg).
By applying several advanced imaging techniques, researchers have resolved the distribution of B-cell antigen receptors on the membranes of immune system lymphocytes.

The B-cell antigen receptors (BCRs) play an important role in the clonal selection of B-cells and their differentiation into antibody-secreting plasma cells. Mature B-cells have both immunoglobulin M (IgM) and IgD types of BCRs, which have identical antigen-binding sites and are both associated with the signaling subunits Ig-alpha and Ig-beta, but differ in their membrane-bound heavy chain isoforms.

Investigators at the BIOSS Centre for Biological Signaling Studies of the University of Freiburg (Germany) applied, two-color direct stochastic optical reconstruction microscopy (dSTORM), transmission electron microscopy (TEM), and the Fab-based proximity-ligation assay (Fab-PLA) to resolve the location and distribution of BCRs in the mature lymphocyte membrane.

Results published in the September 15, 2015, issue of the journal Science Signaling revealed that in contrast to the assumption that BCRs—like all proteins in the membrane—were freely diffusing molecules, dSTORM showed that IgM-BCRs and IgD-BCRs resided in the plasma membrane in different protein islands with average sizes of 150 and 240 nanometers, respectively. Upon B-cell activation, the BCR protein islands became smaller and more dispersed such that the IgM-BCRs and IgD-BCRs were found in close proximity to each other. Moreover, specific stimulation of one class of BCR had minimal effects on the organization of the other. These conclusions were supported by the findings from two-marker transmission electron microscopy and proximity ligation assays.

These results provide direct evidence for the nanoscale compartmentalization of the lymphocyte membrane. In addition, they suggest that upon B-cell activation, the different IgM and IgD protein islands form complexes, which allow the exchange of lipids and proteins. This could be the basis for the association of IgM with Raft-associated lipids and proteins, which is a well-known hallmark of B-cell activation.

The current study was a component of the University of Frieberg's BIOSS nanoscale explorer program (BiNEP), which is dedicated to developing better methods to resolve nano-structures that are smaller than the 250 nanometer diffraction limit of visible light.

Related Links:
BIOSS Centre for Biological Signaling Studies of the University of Freiburg


Platinum Member
Automated Coagulation Analyzer
Hemolumi H6
βeta-Hydroxybutyrate Reagent
β-Hydroxybutyrate LiquiColor®
Gold Member
Platelet Function Analyzer
PL-12
Gold Member
Clinical Chemistry Assay
Sorbitol Dehydrogenase (SDH)

Channels

Clinical Chemistry

view channel
Image: Elevated creatinine levels do not necessarily indicate impaired kidney function: pre-treatment cystatin C measurement is key to assessment (Image Credit: Data panels adapted from Watanabe H, et al. Clin Pharmacol Ther (2026). All icons were obtained from bioicons.com and modified.)

Cystatin C Testing Helps Distinguish Abemaciclib Effect from Kidney Injury

Kidney function monitoring in breast cancer care often relies on serum creatinine, a routine blood marker used to estimate renal function. However, creatinine increases in patients receiving abemaciclib... Read more

Molecular Diagnostics

view channel
Image: These images show breast tumors in a new preclinical model developed by Garvan researchers. The cells carry a fluorescent sensor that lights up blue/green when CDK1—the protein \'engine\' cells need to divide—is switched on. Using it, the team watched CDK1 activity rise as tumors became invasive and stay high in tumors that kept growing despite treatment. (Image Credit: Dr. Max Nobis / Garvan Institute)

Study Finds Potential Marker of Targeted Drug Resistance in Breast Cancer

Estrogen receptor-positive breast cancer is the most common breast cancer subtype and is driven by estrogen. Many patients are treated with CDK4/6 inhibitors alongside hormone therapy, but these drugs... Read more

Hematology

view channel
Image: Mayo Clinic researchers used genetic data from nearly 50,000 participants to identify sickle cell and beta-thalassemia carrier traits, highlighting how population-scale testing can complement existing screening (Image Credit: Adobe Stock)

Genetic Testing Offers Opportunities for Earlier Blood Disorder Carrier Identification

Inherited hemoglobin disorders can affect oxygen transport, yet individuals who carry only a trait may remain unaware of their status. People with sickle cell trait or beta-thalassemia trait often have... Read more

Microbiology

view channel
Image: The test uses serum or plasma from patients with suspected acute infection and symptoms lasting fewer than seven days and generates a score indicating the likelihood of bacterial infection. (Image Credit: Shutterstock)

Rapid Host-Response Assay Gains FDA Clearance to Help Distinguish Bacterial and Viral Infections

Bacterial and viral infections often cause similar symptoms, making early differentiation difficult in emergency and urgent care settings. Clinicians may need to begin treatment before traditional diagnostic... Read more

Pathology

view channel
AI: Artificial intelligence; CNN: Convolutional neural networks; ResNet: Residual neural network. (Xing-hua Gao from The First Hospital of China Medical University, China Image Source Link: https://www.ovid.com/jnls/cmj/fulltext/10.1097/cm9.0000000000004154~deep-learning-based-computational-pathology-technologies)

Review Highlights Progress and Validation Needs for AI in Digital Pathology

Pathology remains the gold standard for disease diagnosis, but clinical laboratories face growing demands for faster, more reproducible diagnostic and prognostic workflows. Digital pathology based on whole-slide... Read more

Industry

view channel
Image: The ExaccType ESR1 dPCR Kit uses digital PCR technology to detect key ESR1 mutations associated with acquired resistance to endocrine therapy. (Photo courtesy of  BIOTYPE)

Collaboration Expands Access to Tests for Cancer Treatment Resistance and Toxicity Risk

Precision medicine in oncology relies on molecular testing to identify biomarkers that can help guide treatment decisions. In hormone receptor-positive, HER2-negative metastatic breast cancer, ESR1 mutations... Read more